News Success for ex-Pfizer scientists with Novartis dermatology s... Novartis is to acquire Ziarco, a privately held UK company focused on developing new treatments in dermatology.
News Pfizer’s eczema drug Eucrisa approved Pfizer has gained FDA approval for Eucrisa, a new eczema treatment which could achieve peak annual sales of $2 billion a year.
News Sanofi’s dermatitis drug dupilumab fast-tracked by FDA Drug could earn $2.8 billion if approved in AD and asthma
News Giving antibiotics to children increases allergy risk Antibiotics linked with asthma and eczema link.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
